IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2016 Holdings

Filed 2016-08-15 | 15 holdings | $88.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celator Pharmaceuticals IncCOM15089R102$67.4K2,232,27276.0%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$12.0K1,580,49113.6%
Synta Pharmaceuticals CorpCOM87162T206$5.7K21,770,6626.4%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$1.3K8,9451.5%
CSW Industrials Inc(CSW)COM126402106$36711,2530.4%
Stellus Cap Invt Corp(SCM)COM858568108$30429,7280.3%
CM FIN IncCOM12574Q103$29533,2470.3%
Paratek Pharmaceuticals IncCOM699374302$26318,9090.3%
Dover Corp(DOV)COM260003108$2233,2240.3%
Cidara Therapeutics IncCOM171757107$19418,8070.2%
Medley Cap CorpCOM58503F106$16724,9130.2%
American Cap SR Floating LTDCOM02504D108$15715,2550.2%
Garrison Cap Inc(GARSUSD)COM366554103$15215,1040.2%
Strongbridge Biopharma PLCSHS USDG85347105$14335,9770.2%
Synta Pharmaceuticals CorpCallCOM87162T206$1972,0000.0%